RESUMEN
Databases of mutations causing Mendelian disease play a crucial role in research, diagnostic and genetic health care and can play a role in life and death decisions. These databases are thus heavily used, but only gene or locus specific databases have been previously reviewed for completeness, accuracy, currency and utility. We have performed a review of the various general mutation databases that derive their data from the published literature and locus specific databases. Only two--the Human Gene Mutation Database (HGMD) and Online Mendelian Inheritance in Man (OMIM)--had useful numbers of mutations. Comparison of a number of characteristics of these databases indicated substantial inconsistencies between the two databases that included absent genes and missing mutations. This situation strengthens the case for gene specific curation of mutations and the need for an overall plan for collection, curation, storage and release of mutation data.
Asunto(s)
Bases de Datos Genéticas , Mutación , Genoma Humano , HumanosRESUMEN
Mutations in the tumor-suppressor p53 gene TP53 are frequent in most human cancers including breast cancer. A new solid phase chemical cleavage of mismatch method (CCM) allowed rapid and efficient screening and analysis of the TP53 gene in DNA samples extracted from tumors of 89 breast cancer patients. The novel CCM technique utilized silica beads and the potassium permanganate/tetraethylammonium chloride (KMnO(4)/TEAC) and hydroxylamine (NH(2)OH) reactions were performed sequentially in a single tube. Mutation analysis involved amplification of five different fragments of the TP53 gene using DNA from the 89 tumor samples, then pairing of the 391 labeled PCR products and forming heteroduplexes. A total of 41 unique signals were revealed in the analysis of TP53 exons 5-9 and eight were identified by direct sequencing. The three novel mutations detected are c.600T>G (p.Asn200Lys), c.601T>G (p.Leu201Val), and c.766-768delACA (p.Thr256del). The detected mutations c.638G>T (p.Arg213Leu), c.730G>T (p.Gly244Cys), and c.758C>T (p.Thr253Ile) have not been reported in breast cancer but have been recorded in tumors of other organs. A previously reported mutation c.535C>T (p.His179Tyr) and a heterozygous polymorphism c.639A>G were also detected. Of the 41 unique signals, 36 were not identified as a sequence change. As direct sequencing requires the mutant allele concentration to be greater than 30% when the mutant allele is present in a mixture with the wild-type allele, the CCM method represents a more sensitive technique requiring a lower mutant allele concentration in the wild-type mixture compared with direct sequencing. This reveals the advantage of CCM for unknown point mutation detection in DNA samples of cancer patients.
Asunto(s)
Disparidad de Par Base/genética , Neoplasias de la Mama/genética , Análisis Mutacional de ADN/métodos , Genes p53/genética , Mutación/genética , Adulto , Anciano , ADN de Neoplasias/genética , ADN de Neoplasias/metabolismo , Femenino , Humanos , Persona de Mediana Edad , Ácidos Nucleicos Heterodúplex/genética , Ácidos Nucleicos Heterodúplex/metabolismo , Federación de RusiaAsunto(s)
Bases de Datos como Asunto , Genoma Humano , Mutación , Humanos , Revisión por Pares , Control de CalidadRESUMEN
The usefulness of any database is dependent on the quality of its content. This is so for mutation databases and has been a continuing concern for those interested in such databases. This article discusses the critical points that determine the quality of the data, such as PCR errors, incomplete scanning, examination of the effect of the variation, and reporting and deposition of the mutations in a database. To illustrate the importance of quality control in mutation curation, nine articles reporting 34 novel phenylketonuria mutations were surveyed for the criteria believed to be important in describing mutations. Many articles were deficient in entries in several criteria, but there was still a high degree of certainty that the described mutations caused disease. Finally, strategies to eliminate errors and to enhance or indicate quality are discussed, including expression, the review process, checking deductions, and typing and encouraging compliance. Models for the future are also discussed.
Asunto(s)
Variación Genética , Genoma , Control de Calidad , ADN/genética , Adhesión a Directriz , Humanos , Fenotipo , Fenilcetonurias/genética , Reacción en Cadena de la PolimerasaRESUMEN
The 7th International HUGO Mutation Database Meeting was held on October 19, 1999 in conjunction with the annual meeting of the American Society of Genetics in San Fransisco, California, U.S.A. Meeting highlights are described, including discussions of topics such as the ethical aspects of variation databases, ethical guidelines which should be established immediately, data protection laws which may affect access to data, and plans to make variation databases financially self-sustaining. A resolution was passed which encourages HUGO and Mutation database Initiative (MDI) collaboration (under the name HUGO-MDI) to provide an integrated, properly funded system of variation databases.
Asunto(s)
Bases de Datos Factuales , Mutación , Alelos , Bases de Datos Factuales/economía , Humanos , Polimorfismo Genético , Programas InformáticosRESUMEN
The 6th International HUGO Mutation Database Meeting was held on March 27, 1999, in conjunction with the Human Genome Meeting HGM 1999, at the Brisbane Conference and Exhibition Centre, Brisbane, Australia. Meeting highlights are described.
Asunto(s)
Bases de Datos Factuales , Mutación , Biología Computacional , Enfermedades Genéticas Congénitas/etnología , Enfermedades Genéticas Congénitas/genética , Humanos , Internet , Sistemas de Registros Médicos Computarizados , Polimorfismo Genético/genética , Programas InformáticosRESUMEN
The complete DNA sequence of the yeast Saccharomyces cerevisiae chromosome XI has been determined. In addition to a compact arrangement of potential protein coding sequences, the 666,448-base-pair sequence has revealed general chromosome patterns; in particular, alternating regional variations in average base composition correlate with variations in local gene density along the chromosome. Significant discrepancies with the previously published genetic map demonstrate the need for using independent physical mapping criteria.
Asunto(s)
Cromosomas Fúngicos , ADN de Hongos , Saccharomyces cerevisiae/genética , Secuencia de Bases , Mapeo Cromosómico , Proteínas Fúngicas/genética , Sistemas de Lectura AbiertaRESUMEN
We report the entire sequence of a 26.4 kb segment of chromosome XI of Saccharomyces cerevisiae. Identification of the known loci URA1, TRP3 and SAC1 revealed a translocation compared to the genetic map. Additionally, six unknown open reading frames have been identified. One of them is similar to catabolic threonine dehydratases. Another one contains characteristic features of membrane transporters. A third one is homologous in half of its length to the prokaryotic hydantoinase HyuA and in the other half to hydatoinase HyuB. A fourth one is homologous to the mammalian phospholipase A2-activating protein. A fifth one, finally, is homologous to the hypothetical open reading frame YCR007C of chromosome III. The sequence has been deposited in the EMBL data library under Accession Number X75951.
Asunto(s)
Amidohidrolasas/genética , Cromosomas Fúngicos , Proteínas/genética , Saccharomyces cerevisiae/genética , Treonina Deshidratasa/genética , Secuencia de Aminoácidos , Secuencia de Bases , Mapeo Cromosómico , Cromosomas Fúngicos/química , Genoma Fúngico , Datos de Secuencia Molecular , Análisis de Secuencia de ADN , Homología de SecuenciaRESUMEN
New yeast episomal vectors having a high degree of utility for cloning and expression in Saccharomyces cerevisiae are described. One vector, pYEULlacZ, is based on pUC19 and employs the pUC19 multiple cloning site for the selection of recombinants in Escherichia coli by lacZ inactivation. In addition, the vector contains two genes, URA3 and leu2-d, for selection of the plasmid in ura3 or leu2 yeast strains. The presence of the leu2-d gene appears to promote replication at high copy numbers. The introduction of CUP1 cassettes allows these plasmids to direct Cu(2+)-regulated production of foreign proteins in yeast. We show the production of a helminth antigen as an example of the vector application.
Asunto(s)
Antígenos Helmínticos/genética , Clonación Molecular/métodos , Cobre/farmacología , Escherichia coli/genética , Vectores Genéticos , Saccharomyces cerevisiae/genética , Animales , Antígenos Helmínticos/análisis , Secuencia de Bases , Clonación Molecular/efectos de los fármacos , Genes Bacterianos , Genes Fúngicos , Histidina/metabolismo , Datos de Secuencia Molecular , Peso Molecular , Sondas de Oligonucleótidos , Plásmidos , Proteínas Recombinantes/análisis , Mapeo Restrictivo , Saccharomyces cerevisiae/efectos de los fármacos , Transformación Genética , Trichostrongylus/genética , Triptófano/metabolismoRESUMEN
Shuttle plasmids, pE1.CUP1B and pE1.CUP1E of 10.6 kb, have been constructed between the metallothionein-encoding CUP1 gene of Saccharomyces cerevisiae and a vector capable of replication in Kluyveromyces lactis. Introduction of these plasmids into K. lactis confers resistance to copper as well as to cadmium and silver. Resistance to these latter metal ions, in the absence of induction by copper, suggested that the CUP1 gene is constitutively expressed in the foreign background. Introduction of the lacZ reporter gene from Escherichia coli into a cloning site downstream from the CUP1 promoter showed that expression of this gene is constitutive in K. lactis but in S. cerevisiae induction by copper is necessary. Sequences upstream from the CUP1 promoter are involved in the constitutive expression since deletion of 91 nucleotides from this region abolishes metal resistance. It is suggested that a K. lactis protein, normally involved in activating transcription of the resident CUP1 gene in the presence of copper, can promote transcription in the absence of metal ion by binding to the upstream activation sequence of the introduced CUP1 gene.